Humana (HUM): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Humana ( HUM) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.4%. By the end of trading, Humana fell $1.42 (-1.6%) to $89.89 on average volume. Throughout the day, 1,045,760 shares of Humana exchanged hands as compared to its average daily volume of 1,346,700 shares. The stock ranged in price between $89.60-$91.33 after having opened the day at $91.33 as compared to the previous trading day's close of $91.31. Other companies within the Health Care sector that declined today were: Mast Therapeutics ( MSTX), down 38.4%, Organovo Holdings ( ONVO), down 14.0%, Aoxing Pharmaceutical Company ( AXN), down 12.0% and LipoScience ( LPDX), down 10.4%.

Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Healthcare Services. Humana has a market cap of $14.4 billion and is part of the health services industry. Shares are up 33.0% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Humana a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Stereotaxis ( STXS), up 74.8%, Aastrom Biosciences ( ASTM), up 35.6%, CEL-SCI Corporation ( CVM), up 19.2% and Skystar Bio-Pharmaceutical Company ( SKBI), up 17.5% , were all gainers within the health care sector with Perrigo Company ( PRGO) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Boeing, Pure Storage, Activision Blizzard: 'Mad Money' Lightning Round

The Makings of Another Huge Rebound?

Healthcare Management Stocks Look Too Pricey for Activists

Tenet Dives After Worse Than Expected Quarter Leads to Lower 2017 Outlook